HealthLeap raises $30M Series A for AI that flags at-risk hospital patients
What's the deal? HealthLeapDealroom has a profile for this one. Try Dealroom → has raised a $30 million Series A led by Hummingbird Ventures for its AI platform that screens hospital patients for conditions that often go undiagnosed. The financing also includes an $8 million seed round co-led by Sequoia CapitalDealroom has a profile for this one. Try Dealroom → and First Round Capital. The company is not disclosing its valuation.
What's the endgame? Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, HealthLeap plugs into a hospital's electronic health record system and uses language models to pull signals from clinicians' written notes — references to recent weight loss or difficulty swallowing — alongside labs and vitals. The software doesn't diagnose; it writes a nightly risk score into care teams' workflows to flag patients who may need a closer look.
The platform, now deployed in more than 50 hospitals, screens for conditions such as malnutrition and delirium. It has also built programs for aspiration pneumonia, pressure ulcers, and congestive heart failure readmission risk, which are undergoing clinical validation.
Why malnutrition? "A patient's chart holds two kinds of data. Labs, weights, and vital signs sit in structured fields, but the most telling signs sit in clinicians' written notes," chief executive officer Josiah Meyer said. Research suggests 20% to 50% of hospital inpatients are malnourished, a condition linked to longer stays, infections, and higher mortality.
By the numbers: HealthLeap has grown from three hospital partners to more than 50 over the past year, with customers including Penn MedicineDealroom has a profile for this one. Try Dealroom →, Cedars-SinaiDealroom has a profile for this one. Try Dealroom →, IntermountainDealroom has a profile for this one. Try Dealroom →, Houston MethodistDealroom has a profile for this one. Try Dealroom →, and Emory HealthcareDealroom has a profile for this one. Try Dealroom →. Revenue grew more than 10x over the same period. At the Hospital of the University of PennsylvaniaDealroom has a profile for this one. Try Dealroom →, its malnutrition program drove $23.8 million in annualised financial impact — $6.3 million from reimbursement and $17.5 million from shorter stays.
The startup sells three-year contracts priced by a hospital's licensed bed count, plus an outcome-based model. "To date, every customer has seen a 5x hard ROI or more, in some cases over 20x annual total ROI," Meyer said.
What's next? HealthLeap plans to spend the fresh cash on engineering, product, sales, and customer success as it adds support for more conditions. It ultimately wants to cover more than 40 major health conditions and expand into outpatient and home care.
The signal: The raise sits in the upper tier of its category by size, reflecting investor appetite for AI tools that mine unstructured clinical notes to catch what structured data misses. With hospitals facing margin pressure, outcome-based pricing tied to validated ROI is emerging as a way to sell AI into healthcare.
Read more: TechCrunch
Image credit: HealthLeap
